It looks like this equity (ARYX.PK) cannot be resolved or is no longer available, but we have found another equity that may match the characteristics of what you are looking for. Please check ARYX ARYx Therapeutics Inc to make sure you are using current equity.
ARYx Therapeutics Inc cannot be verified agains its exchange. It seems like ARYx is not available for investing. Please verify the symbol is currently traded on OTC Market. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.Check current 30 days ARYx correlation with market (S&P 500)
The median price of ARYx for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 0.0 with a coefficient of variation of 291.04. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period.
ARYx Therapeutics Inc [ARYX] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with current market capitalization of 334.61 K. ARYx Therapeutics Inc has 33.46 M outstanding shares of which 75.67 K shares are presently shorted by private and institutional investors with about 0.8 days to cover all short positions.
ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with commercialized drugs in the United States. more
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory